analytical method transfer; transfer methodology; tolerance interval; risk; statistical approaches
Abstract :
[en] Two new statistical approaches to assess the validity of the transfer of a LC-UV method for the determination of fenofibrate and fenofibric acid were investigated and compared to the conventional approaches generally used in this domain. These new approaches, namely the Tolerance Interval and the Risk approaches, are based on the simultaneous evaluation of the systematic (or trueness) and random (or precision) errors of the transfer into a single criterion called total error (or accuracy). The results of the transfer showed that only the total error based approaches fulfilled the objective of an analytical method transfer, i.e. to give guarantees that each future measurement made by the receiving laboratory will be close enough to the true value of the analyte in the sample. Furthermore the Risk approach was the most powerful one and allowed the estimation of the risk to have future measurements out of specification in the receiving laboratory, therefore being a risk management tool. (c) 2006 Elsevier B.V. All rights reserved.
Disciplines :
Chemistry Pharmacy, pharmacology & toxicology
Author, co-author :
Rozet, Eric ; Université de Liège - ULiège > Chimie analytique
Mertens, Bénédicte; Galephar
Dewé, Walthère ; Université de Liège - ULiège > Analyse des médicaments
Ceccato, Attilio ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments
Govaerts, Bernadette; Université Catholique de Louvain - UCL > Institute of Statistics
Boulanger, Bruno ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments
Chiap, Patrice ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments
Streel, Bruno; Galephar
Crommen, Jacques ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Ment W. FDA News Inf. 2 (2001) 1-3
Analytical procedure/technology transfer, ISPE Guideline, 2003, pp. 23-24.
Minois-Offroy F., Appriou Y., Brousset V., Chapuzet E., de Fontenay G., Dewé W., Dumas E., Ellie C., Galiay M., Lefebvre N., Mottu P., Quint M.P., and Schoeffter F. STP Pharma Pratiques 12 (2002) 337-343
Kringle R., Khan-Malek R., Snikeris F., Munden P., Agut C., and Bauer M. Drug Inf. J. 35 (2001) 1271-1288
W. Dewé, B. Govaerts, B. Boulanger, E. Rozet, P. Chiap, Ph. Hubert, Chemom. Intell. Lab. Syst., submitted for publication.
W. Dewé, B. Govaerts, B. Boulanger, E. Rozet, D. Yapi, B. Mertens, P. Chiap, Ph. Hubert, Proceedings of the Congress Chimiométrie 2004, France, Paris.
Hubert Ph., N'guyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., and Valat L. STP Pharma Pratiques 13 (2003) 101-138
Hubert Ph., N'guyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewé W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., and Valat L. J. Pharm. Biomed. Anal. 36 (2004) 579-586
Boulanger B., Dewe W., Chiap P., Crommen J., and Hubert Ph. J. Pharm. Biomed. Anal. 32 (2003) 753-765
Schuirmann D.J. J. Pharmaco. Biopharm. 15 (1987) 657-680
Hartmann C., Smeyers-Verbeke J., Penninckx W., Vander Heyden Y., Vankeerberghen P., and Massart D.L. Anal. Chem. 67 (1995) 4491-4499
ISO 5725-1, Application of the statistics-accuracy (trueness and precision) of the results and methods of measurement. Part 1. General principles and definitions, International Organization for Standardization (ISO), Geneva, Switzerland.
ISO 5725-2, Accuracy (trueness and precision) of measurement methods and results, International Organization for Standardization (ISO), Geneva, Switzerland.
Food and Drug Administration, Process Analytical Technology (PAT) Initiative, 2004, http://www.fda.gov/cder/guidance/6419fnl.htm.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.